{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:21:55Z","timestamp":1783650115790,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11010-024-05125-7","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T06:02:07Z","timestamp":1728280927000},"page":"2487-2500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Microrna363-5p targets thrombospondin3 to regulate pathological cardiac remodeling"],"prefix":"10.1007","volume":"480","author":[{"given":"Yu-kun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-huai","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-xue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"5125_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2023.102071","volume":"34","author":"A Jeong","year":"2023","unstructured":"Jeong A, Lim Y, Kook T, Kwon DH, Cho YK, Ryu J, Lee YG, Shin S, Choe N, Kim YS, Cho HJ, Kim JC, Choi Y, Lee SJ, Kim HS, Kee HJ, Nam KI, Ahn Y, Jeong MH, Park WJ, Kim YK, Kook H (2023) Circular RNA circSMAD4 regulates cardiac fibrosis by targeting miR-671-5p and FGFR2 in cardiac fibroblasts. Mol Ther Nucleic Acids 34:1\u201319. https:\/\/doi.org\/10.1016\/j.omtn.2023.102071","journal-title":"Mol Ther Nucleic Acids"},{"key":"5125_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.120.317244","author":"J Li","year":"2021","unstructured":"Li J, Salvador AM, Li G, Valkov N, Ziegler O, Yeri A et al (2021) Mir-30d regulates cardiac remodeling by intracellular and paracrine signaling. Circ Res. https:\/\/doi.org\/10.1161\/circresaha.120.317244","journal-title":"Circ Res"},{"issue":"12","key":"5125_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","volume":"63","author":"AP Ambrosy","year":"2014","unstructured":"Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M et al (2014) The global health and economic burden of hospitalizations for heart failure. J Am Coll Cardiol 63(12):1123\u20131133. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.053","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5125_CR4","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/cvr\/cvab248","volume":"118","author":"G Li","year":"2022","unstructured":"Li G, Shao Y, Guo HC, Zhi Y, Qiao B, Ma K et al (2022) MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling. Cardiovasc Res 118(9):2139\u20132151. https:\/\/doi.org\/10.1093\/cvr\/cvab248","journal-title":"Cardiovasc Res"},{"key":"5125_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/nyas.14813","volume":"1516","author":"L Zhao","year":"2022","unstructured":"Zhao L, Qi F, Du D, Wu N (2022) Histone demethylase KDM3C regulates the lncRNA GAS5\u2013miR-495-3p\u2013PHF8 axis in cardiac hypertrophy. Ann N Y Acad Sci 1516:286\u2013299. https:\/\/doi.org\/10.1111\/nyas.14813","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"5125_CR6","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1002\/ctm2.693","volume":"12","author":"RR Gaddam","year":"2022","unstructured":"Gaddam RR, Kim YR, Jacobs JS, Yoon JY, Li Q, Cai A et al (2022) The microRNA-204-5p inhibits APJ signalling and confers resistance to cardiac hypertrophy and dysfunction. Clin Transl Med 12(1):e693. https:\/\/doi.org\/10.1002\/ctm2.693","journal-title":"Clin Transl Med"},{"issue":"2","key":"5125_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00018-023-04699-7","volume":"80","author":"CX Ma","year":"2023","unstructured":"Ma CX, Wei ZR, Sun T, Yang MH, Sun YQ, Kai KL et al (2023) Circ-sh3rf3\/GATA-4\/miR-29a regulatory axis in fibroblast\u2013myofibroblast differentiation and myocardial fibrosis. Cell Mol Life Sci 80(2):50. https:\/\/doi.org\/10.1007\/s00018-023-04699-7","journal-title":"Cell Mol Life Sci"},{"key":"5125_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s13105-021-00861-6","volume":"78","author":"H-Y Deng","year":"2022","unstructured":"Deng H-Y, He Z-Y, Dong Z-C, Zhang Y-L, Han X, Li H-H (2022) MicroRNA-451a attenuates angiotensin II\u2013induced cardiac fibrosis and inflammation by directly targeting T-box1. J Physiol Biochem 78:257\u2013269. https:\/\/doi.org\/10.1007\/s13105-021-00861-6","journal-title":"J Physiol Biochem"},{"issue":"13","key":"5125_CR9","doi-asserted-by":"publisher","first-page":"e152783","DOI":"10.1172\/jci10.1172\/jci.insight.152783DS1","volume":"7","author":"KCV Subbaiah","year":"2022","unstructured":"Subbaiah KCV, Wu J, Tang WHW, Yao P (2022) FAM114A1 influences cardiac pathological remodeling by regulating angiotensin II signaling. JCI Insight 7(13):e152783. https:\/\/doi.org\/10.1172\/jci10.1172\/jci.insight.152783DS1","journal-title":"JCI Insight"},{"key":"5125_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.yjmcc.2020.11.015","volume":"152","author":"W Ge","year":"2021","unstructured":"Ge W, Hou C, Zhang W, Guo X, Gao P, Song X, Gao R, Liu Y, Guo W, Li B, Zhao H, Wang J (2021) Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation. J Mol Cell Cardiol 152:52\u201368. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.11.015","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"5125_CR11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ejhf.2493","volume":"24","author":"A Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez A, Richards AM, de Boer RA, Thum T, Arfsten H, H\u00fclsmann M et al (2022) Cardiac remodelling \u2013 Part 1: from cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 24(6):927\u2013943. https:\/\/doi.org\/10.1002\/ejhf.2493","journal-title":"Eur J Heart Fail"},{"key":"5125_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.202012710","volume":"13","author":"J Wu","year":"2021","unstructured":"Wu J, Venkata Subbaiah KC, Jiang F, Hedaya O, Mohan A, Yang T, Welle K, Ghaemmaghami S, Tang WHW, Small E, Yan C, Yao P (2021) MicroRNA-574 regulates FAM210A expression and influences pathological cardiac remodeling. EMBO Mol Med 13:1\u201320. https:\/\/doi.org\/10.15252\/emmm.202012710","journal-title":"EMBO Mol Med"},{"key":"5125_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8889195","volume":"2021","author":"H Zhan","year":"2021","unstructured":"Zhan H, Huang F, Niu Q, Jiao M, Han X, Zhang K et al (2021) Downregulation of miR-128 Ameliorates Ang II-induced cardiac remodeling via SIRT1\/PIK3R1 multiple targets. Oxid Med Cell Longev 2021:1\u201317. https:\/\/doi.org\/10.1155\/2021\/8889195","journal-title":"Oxid Med Cell Longev"},{"key":"5125_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910574","author":"CH Hsu","year":"2021","unstructured":"Hsu CH, Liu IF, Kuo HF, Li CY, Lian WS, Chang CY et al (2021) miR-29a-3p\/THBS2 axis regulates PAH-induced cardiac fibrosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms221910574","journal-title":"Int J Mol Sci"},{"issue":"24","key":"5125_CR15","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1093\/hmg\/ddx378","volume":"26","author":"N Urao","year":"2017","unstructured":"Urao N, Mirza RE, Corbiere TF, Hollander Z, Borchers CH, Koh TJ (2017) Thrombospondin-1 and disease progression in dysferlinopathy. Hum Mol Genet 26(24):4951\u20134960. https:\/\/doi.org\/10.1093\/hmg\/ddx378","journal-title":"Hum Mol Genet"},{"key":"5125_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000141019.20332.3e","author":"B Schroen","year":"2004","unstructured":"Schroen B, Heymans S, Sharma U, Blankesteijn WM, Pokharel S, Cleutjens JPM et al (2004) Thrombospondin-2 Is essential for myocardial matrix integrity. Circ Res. https:\/\/doi.org\/10.1161\/01.RES.0000141019.20332.3e","journal-title":"Circ Res"},{"issue":"1","key":"5125_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41467-018-08026-8","volume":"10","author":"TG Schips","year":"2019","unstructured":"Schips TG, Vanhoutte D, Vo A, Correll RN, Brody MJ, Khalil H et al (2019) Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability. Nat Commun 10(1):76. https:\/\/doi.org\/10.1038\/s41467-018-08026-8","journal-title":"Nat Commun"},{"issue":"11","key":"5125_CR18","doi-asserted-by":"publisher","first-page":"H1486","DOI":"10.1152\/ajpheart.00046.2016","volume":"310","author":"T Palao","year":"2016","unstructured":"Palao T, Rippe C, van Veen H, VanBavel E, Sward K, Bakker EN (2016) Thrombospondin-4 knockout in hypertension protects small-artery endothelial function but induces aortic aneurysms. Am J Physiol Heart Circ Physiol 310(11):H1486\u2013H1493. https:\/\/doi.org\/10.1152\/ajpheart.00046.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"5125_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/MOL.0b013e3283642912","volume":"24","author":"O Stenina-Adognravi","year":"2013","unstructured":"Stenina-Adognravi O (2013) Thrombospondins: old players, new games. Curr Opin Lipidol 24(5):401\u2013409. https:\/\/doi.org\/10.1097\/MOL.0b013e3283642912","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"5125_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/bcpt.12026","volume":"112","author":"E Mustonen","year":"2013","unstructured":"Mustonen E, Ruskoaho H, Rysa J (2013) Thrombospondins, potential drug targets for cardiovascular diseases. Basic Clin Pharmacol Toxicol 112(1):4\u201312. https:\/\/doi.org\/10.1111\/bcpt.12026","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"5125_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.141713","author":"OI Stenina","year":"2007","unstructured":"Stenina OI, Topol EJ, Plow EF (2007) Thrombospondins, their polymorphisms, and cardiovascular disease. Arterioscler Thromb Vasc Biol. https:\/\/doi.org\/10.1161\/ATVBAHA.107.141713","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"5125_CR22","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/ATVBAHA.122.318904\/10.5141Q","volume":"43","author":"B Singla","year":"2023","unstructured":"Singla B, Aithbathula RV, Pervaiz N, Kathuria I, Swanson M, Ekuban FA et al (2023) CD47 activation by Thrombospondin-1 in lymphatic endothelial cells suppresses lymphangiogenesis and promotes atherosclerosis. Arterioscler Thromb Vasc Biol 43(7):1234\u20131250. https:\/\/doi.org\/10.1161\/ATVBAHA.122.318904\/10.5141Q","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"5125_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a009712","volume":"3","author":"JC Adams","year":"2011","unstructured":"Adams JC, Lawler J (2011) The thrombospondins. Cold Spring Harb Perspect Biol 3(10):1\u201329. https:\/\/doi.org\/10.1101\/cshperspect.a009712","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"22","key":"5125_CR24","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/s41388-023-02692-9\/6.63401Q","volume":"42","author":"Y Hong","year":"2023","unstructured":"Hong Y, Kim I, Moon H, Lee J, Lertpatipanpong P, Ryu CH et al (2023) Novel thrombospondin-1 transcript exhibits distinctive expression and activity in thyroid tumorigenesis. Oncogene 42(22):1832\u20131842. https:\/\/doi.org\/10.1038\/s41388-023-02692-9\/6.63401Q","journal-title":"Oncogene"},{"issue":"87","key":"5125_CR25","first-page":"1","volume":"6","author":"A Costa","year":"2013","unstructured":"Costa A, Afonso J, Os\u00f3rio C, Gomes AL, Caiado F, Valente J et al (2013) miR-363-5p regulates endothelial cell properties and their communication with hematopoietic precursor cells. J Hematol Oncol 6(87):1\u201312","journal-title":"J Hematol Oncol"},{"key":"5125_CR26","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","volume":"88","author":"HA Rockman","year":"1991","unstructured":"Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ et al (1991) Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci 88:8277\u20138281","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"5125_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/21655979.2021.2009968","volume":"13","author":"G Jia","year":"2022","unstructured":"Jia G, Liang C, Li W, Dai H (2022) MiR-410-3p facilitates Angiotensin II-induced cardiac hypertrophy by targeting Smad7. Bioengineered 13(1):119\u2013127. https:\/\/doi.org\/10.1080\/21655979.2021.2009968","journal-title":"Bioengineered"},{"issue":"55","key":"5125_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-022-00349-1","volume":"27","author":"R Zhang","year":"2022","unstructured":"Zhang R, Qu Y, Ji Z, Hao C, Su Y, Yao Y, Zuo W, Chen X, Yang M, Ma G (2022) METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221\/222 maturation in an m6A-dependent manner. Cell Mol Biol Lett 27(55):1\u201319. https:\/\/doi.org\/10.1186\/s11658-022-00349-1","journal-title":"Cell Mol Biol Lett"},{"issue":"6","key":"5125_CR29","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2012.03.050","volume":"149","author":"JM Lynch","year":"2012","unstructured":"Lynch JM, Maillet M, Vanhoutte D, Schloemer A, Sargent MA, Blair NS et al (2012) A thrombospondin-dependent pathway for a protective ER stress response. Cell 149(6):1257\u20131268. https:\/\/doi.org\/10.1016\/j.cell.2012.03.050","journal-title":"Cell"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05125-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-05125-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05125-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T22:36:36Z","timestamp":1743719796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-05125-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5125"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-05125-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4371143\/v1","asserted-by":"object"}]},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"assertion":[{"value":"5 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures involving animals were conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved (IACUC-BNT-2023-010) by the Experimental Animal Ethics Committee of BEIENTE Biotechnology Co., Ltd, HuBei, China (SYSK-2021-0119).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}